Daniel Meibom
Impact in
- Physiology top 10%
- Adenosine and Purinergic Signaling
-
- Protein Degradation and Inhibitors
Papers in
-
- Adenosine and Purinergic Signaling 2
-
- Protease and Inhibitor Mechanisms 3
- Co-authors
- Vasanthanathan Poongavanam (5 shared papers)Jan O. Kihlberg (5 shared papers)Máté Erdélyi (4 shared papers)Anja Giese (3 shared papers)Yoseph Atilaw (3 shared papers)Lutz Eric Lehmann (3 shared papers)Stephan Siegel (1 shared paper)Ekkehard Winterfeldt (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (7 papers)ChemMedChem (3 papers)ACS Medicinal Chemistry Letters (2 papers)ACS Omega (1 paper)Chemical Communications (1 paper)
- Partner nations
- GermanySwedenUnited States
In The Last Decade
Daniel Meibom
17 papers receiving 530 citations
Peers
Comparison fields: 5 of 43
- Physiology 34
- Molecular Biology 309
- Computational Theory and Mathematics 58
- Cancer Research 44
- Organic Chemistry 64
Countries citing papers authored by Daniel Meibom
This map shows the geographic impact of Daniel Meibom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Meibom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Meibom more than expected).
Fields of papers citing papers by Daniel Meibom
This network shows the impact of papers produced by Daniel Meibom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Meibom. The network helps show where Daniel Meibom may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Meibom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 147 | |
| 2 | 2022 | 106 | |
| 3 | 2015 | 59 | |
| 4 | 2017 | 43 | |
| 5 | 2015 | 33 | |
| 6 | 2023 | 31 | |
| 7 | 2024 | 29 | |
| 8 | 2020 | 26 | |
| 9 | 2023 | 23 | |
| 10 | 1996 | 15 | |
| 11 | 2025 | 14 | |
| 12 | 2018 | 11 | |
| 13 | 2022 | 8 | |
| 14 | 2024 | 4 | |
| 15 | 2003 | 3 | |
| 16 | 2009 | 3 | |
| 17 | 2023 | 2 |
About Daniel Meibom
Daniel Meibom is a scholar working on Physiology, Cancer Research, Molecular Biology, Organic Chemistry and Pharmaceutical Science, having authored 17 papers that have together received 557 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (5 papers), Protease and Inhibitor Mechanisms (3 papers), Asymmetric Synthesis and Catalysis (2 papers), Organic Chemistry Cycloaddition Reactions (2 papers), Adenosine and Purinergic Signaling (2 papers), Synthesis and Characterization of Heterocyclic Compounds (1 paper), Fluorine in Organic Chemistry (1 paper) and Receptor Mechanisms and Signaling (1 paper). The work is most often cited by research in Physiology (34 citations), Molecular Biology (309 citations), Computational Theory and Mathematics (58 citations), Cancer Research (44 citations) and Organic Chemistry (64 citations). Daniel Meibom has collaborated with scholars based in Germany, Sweden and United States. Frequent co-authors include Vasanthanathan Poongavanam, Jan O. Kihlberg, Máté Erdélyi, Anja Giese, Yoseph Atilaw, Lutz Eric Lehmann, Stephan Siegel, Ekkehard Winterfeldt, Joachim Mittendorf and Raimund Kast. Their work appears in journals such as Journal of Medicinal Chemistry, ChemMedChem, ACS Medicinal Chemistry Letters, ACS Omega and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.